(UroToday.com) At the European Society of Medical Oncology – 2020 Virtual Congress (ESMO), Dr. David Margel presented data regarding the first round of screening from an imaging-based prostate cancer screening program among BRCA mutation carriers. There are clear guidelines for screening female BRCA-carriers for breast and ovarian cancer, however male BRCA-carrier screening for prostate cancer has largely been unstandardized. The aim of this study was to test the prevalence of prostate cancer among BRCA-carriers in Israel and to examine screening-strategies, specifically the use of prostate-specific antigen (PSA) and mpMRI.